Bit of a false break of resistance. Sometimes these pullbacks are privileged information driven but if so we won't know until it comes out.
Gee whiz. Copping a flogging today as the sentiment rises to out at any price. Is Slipperz any the wiser here on the rush to the door?
I think the flogging is on the back of Dendreons results yesterday in the US, and unfortunately the cancer has spread to PRR (excuse the pun).
http://www.msnbc.msn.com/id/44012400/ns/business-personal_finance/
well, thought that I will post a point regarding DNDN (our sibling? since PRR is often compared with DNDN)
it dips to $11 in the after hour trade
18:15 $ 13 100
18:14 $ 11 201,900
17:08 $ 35.2849 2,600
16:48 $ 35.2849 200
16:48 $ 35.2849 100
oh well, who is that who dumps ~$2m at 18:14?
I just cannot think of any logical reason to dump it at $11 seeing the previous trade is still $35
Dendreon Corporation
(NasdaqGS: DNDN )
Real Time 12.93 Down 22.91 (63.92%) 23:50
This is looking really REALLY BAD atm. If that is anything to go by......
Holding long and strong
Amen to that (=. It takes a lot of courage though, in a market like this, NO ONE has time for a speccy biotech stock that is our Prima. I'm pretty sure it's going to get a LOT worse before it gets better, so I'm gonna stash away my PRR shares till 2018 when they're worth $4 each post FDA approval =).
Been looking at the Fraunhofer site and they are pretty big potatoes in euroland. http://www.fraunhofer.de/en/about-fraunhofer/
Our association with them is very positive for the future with regard to approval from the EU regulatory authorities.
Nice they gave us 4 million as well!
What happens on monday is absolutely unbeknownst to anyone. I'm just worried about the Phase IIb results getting released.
It shocks me to see the number of people not caring at all about these crucial, crucial milestones for PRR and focusing on market sentiment instead. Eyes on the prize, guys! A worldwide collapse won't worry me one bit - Women will (most unfortunately) keep getting Ovarian cancer and someone needs to find a cure; the demand will ALWAYS be there. If the SP falls, so be it - we are in pure speculation mode developing our product and I don't blame the market - After all, we have no revenue.
What WILL terrify me, however, are results actually relating to CVac. If it so happens that trial results are delayed, knocked back or unsatisfactory, that is when I'll throw my hands up and admit we're screwed. Until then, CVac seems to be doing absolutely fine - what more could you ask for at this stage? Approval in Dubai, media exposure in Australia, encouraging results in Phase IIa, SPP oversubscription, funding from Germany. All signs point to the damn thing working. We're cashed up and ready to go. The journey continues for PRR.
If Mr. Rogers can take us on this journey for the next six years the same way we have so far, we will have an explosion of revenue given the manufacturing process is scaled well (perhaps even before the FDA approves Cvac). We're set for worldwide penetration - Europe, US, Australia and now the middle east. To top it off, we can learn from DNDN, where they've failed in accounting/rolling out the immunotherapy across practices, we can succeed. For those who believe, stop pressing F5, wake up on one fine morning in 2019 and put in a sell order for $5.50 =).
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?